Implementation of HPV-based cervical cancer screening in an organised regional screening programme: 3 years of experience

Cytology at the Time of HPV: Some Things to Think about when Discussing HPV

(2016) Kristi Valentine et al.   ACTA CYTOLOGICA

Human papillomavirus test with cytology triage in organized screening for cervical cancer

(2016) Olga Veijalainen et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Primary HPV testing: a proposal for co-testing in initial rounds of screening to optimise sensitivity of cervical cancer screening

(2016) A. Herbert   CYTOPATHOLOGY

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

(2015) M. Arbyn et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening

(2014) Hae-Sun Chung et al.   JOURNAL OF VIROLOGICAL METHODS

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland

(2013) M K Leinonen et al.   BRITISH JOURNAL OF CANCER

Comparing the performance of six human papillomavirus tests in a screening population

(2013) J Cuzick et al.   BRITISH JOURNAL OF CANCER

Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening

(2013) A. T. Hesselink et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

New Technologies and Procedures for Cervical Cancer Screening

(2012) Jack Cuzick et al.   VACCINE

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland

(2012) M. K. Leinonen et al.   BMJ-British Medical Journal

Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting

(2011) F. M. Carozzi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening

(2011) M. Poljak et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

(2011) Philip E Castle et al.   LANCET ONCOLOGY

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting

(2009) Maarit Leinonen et al.   JNCI-Journal of the National Cancer Institute

Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland

(2008) Maarit Leinonen et al.   INTERNATIONAL JOURNAL OF CANCER

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial

(2008) Francesca Carozzi et al.   LANCET ONCOLOGY

Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries

(2008) Jack Cuzick et al.   VACCINE